Present On Admission Exempt Codes
ICD-10-CM diagnosis codes exempt from POA reporting based on the official FY2027 CMS POA exempt list.
Advertisements
Codes on this list
38,399 codes, page 271 of 384.
- T44.2X2DPoisoning by ganglionic blocking drugs, intentional self-harm, subsequent encounter
- T44.2X2SPoisoning by ganglionic blocking drugs, intentional self-harm, sequela
- T44.2X3DPoisoning by ganglionic blocking drugs, assault, subsequent encounter
- T44.2X3SPoisoning by ganglionic blocking drugs, assault, sequela
- T44.2X4DPoisoning by ganglionic blocking drugs, undetermined, subsequent encounter
- T44.2X4SPoisoning by ganglionic blocking drugs, undetermined, sequela
- T44.2X5DAdverse effect of ganglionic blocking drugs, subsequent encounter
- T44.2X5SAdverse effect of ganglionic blocking drugs, sequela
- T44.2X6DUnderdosing of ganglionic blocking drugs, subsequent encounter
- T44.2X6SUnderdosing of ganglionic blocking drugs, sequela
- T44.3X1DPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), subsequent encounter
- T44.3X1SPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), sequela
- T44.3X2DPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, subsequent encounter
- T44.3X2SPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, sequela
- T44.3X3DPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter
- T44.3X3SPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, sequela
- T44.3X4DPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter
- T44.3X4SPoisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, sequela
- T44.3X5DAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
- T44.3X5SAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
- T44.3X6DUnderdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
- T44.3X6SUnderdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
- T44.4X1DPoisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter
- T44.4X1SPoisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela
- T44.4X2DPoisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter
- T44.4X2SPoisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela
- T44.4X3DPoisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter
- T44.4X3SPoisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela
- T44.4X4DPoisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter
- T44.4X4SPoisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela
- T44.4X5DAdverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter
- T44.4X5SAdverse effect of predominantly alpha-adrenoreceptor agonists, sequela
- T44.4X6DUnderdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter
- T44.4X6SUnderdosing of predominantly alpha-adrenoreceptor agonists, sequela
- T44.5X1DPoisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter
- T44.5X1SPoisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), sequela
- T44.5X2DPoisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter
- T44.5X2SPoisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, sequela
- T44.5X3DPoisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounter
- T44.5X3SPoisoning by predominantly beta-adrenoreceptor agonists, assault, sequela
- T44.5X4DPoisoning by predominantly beta-adrenoreceptor agonists, undetermined, subsequent encounter
- T44.5X4SPoisoning by predominantly beta-adrenoreceptor agonists, undetermined, sequela
- T44.5X5DAdverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter
- T44.5X5SAdverse effect of predominantly beta-adrenoreceptor agonists, sequela
- T44.5X6DUnderdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter
- T44.5X6SUnderdosing of predominantly beta-adrenoreceptor agonists, sequela
- T44.6X1DPoisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter
- T44.6X1SPoisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), sequela
- T44.6X2DPoisoning by alpha-adrenoreceptor antagonists, intentional self-harm, subsequent encounter
- T44.6X2SPoisoning by alpha-adrenoreceptor antagonists, intentional self-harm, sequela
- T44.6X3DPoisoning by alpha-adrenoreceptor antagonists, assault, subsequent encounter
- T44.6X3SPoisoning by alpha-adrenoreceptor antagonists, assault, sequela
- T44.6X4DPoisoning by alpha-adrenoreceptor antagonists, undetermined, subsequent encounter
- T44.6X4SPoisoning by alpha-adrenoreceptor antagonists, undetermined, sequela
- T44.6X5DAdverse effect of alpha-adrenoreceptor antagonists, subsequent encounter
- T44.6X5SAdverse effect of alpha-adrenoreceptor antagonists, sequela
- T44.6X6DUnderdosing of alpha-adrenoreceptor antagonists, subsequent encounter
- T44.6X6SUnderdosing of alpha-adrenoreceptor antagonists, sequela
- T44.7X1DPoisoning by beta-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter
- T44.7X1SPoisoning by beta-adrenoreceptor antagonists, accidental (unintentional), sequela
- T44.7X2DPoisoning by beta-adrenoreceptor antagonists, intentional self-harm, subsequent encounter
- T44.7X2SPoisoning by beta-adrenoreceptor antagonists, intentional self-harm, sequela
- T44.7X3DPoisoning by beta-adrenoreceptor antagonists, assault, subsequent encounter
- T44.7X3SPoisoning by beta-adrenoreceptor antagonists, assault, sequela
- T44.7X4DPoisoning by beta-adrenoreceptor antagonists, undetermined, subsequent encounter
- T44.7X4SPoisoning by beta-adrenoreceptor antagonists, undetermined, sequela
- T44.7X5DAdverse effect of beta-adrenoreceptor antagonists, subsequent encounter
- T44.7X5SAdverse effect of beta-adrenoreceptor antagonists, sequela
- T44.7X6DUnderdosing of beta-adrenoreceptor antagonists, subsequent encounter
- T44.7X6SUnderdosing of beta-adrenoreceptor antagonists, sequela
- T44.8X1DPoisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), subsequent encounter
- T44.8X1SPoisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), sequela
- T44.8X2DPoisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, subsequent encounter
- T44.8X2SPoisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, sequela
- T44.8X3DPoisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, subsequent encounter
- T44.8X3SPoisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, sequela
- T44.8X4DPoisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, subsequent encounter
- T44.8X4SPoisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, sequela
- T44.8X5DAdverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
- T44.8X5SAdverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela
- T44.8X6DUnderdosing of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
- T44.8X6SUnderdosing of centrally-acting and adrenergic-neuron-blocking agents, sequela
- T44.901DPoisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter
- T44.901SPoisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), sequela
- T44.902DPoisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter
- T44.902SPoisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, sequela
- T44.903DPoisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, subsequent encounter
- T44.903SPoisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, sequela
- T44.904DPoisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, subsequent encounter
- T44.904SPoisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, sequela
- T44.905DAdverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter
- T44.905SAdverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela
- T44.906DUnderdosing of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter
- T44.906SUnderdosing of unspecified drugs primarily affecting the autonomic nervous system, sequela
- T44.991DPoisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter
- T44.991SPoisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), sequela
- T44.992DPoisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter
- T44.992SPoisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, sequela
- T44.993DPoisoning by other drug primarily affecting the autonomic nervous system, assault, subsequent encounter
- T44.993SPoisoning by other drug primarily affecting the autonomic nervous system, assault, sequela